1179 MB501: a novel anti-PD-1 x IL-2 variant enhancing the anti-tumor efficacy by empowering activated T cells with improved drug tolerability by Bom Park, Hyojoo Bang, So Woon Kim, Sunjung Cho, Youngsam Kim, Suyoon Kim, Minwoo Kim, Youngjin Park, Jun-Eui Park